Oscillatory PEP Device with Integrated Medicated Nebulizer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current respiratory therapy devices for patients with mucus-producing conditions do not effectively combine positive expiratory pressure (PEP) therapy with medicated aerosol drug delivery, limiting the treatment's efficacy for conditions like COPD and cystic fibrosis.
Innovation Solution
A single-patient use positive oscillatory expiratory pressure respiratory therapy device integrated with a medicated aerosol nebulizer, featuring an expiratory-air-driven oscillatory rocker assembly that generates oscillatory pressure and frequency control, allowing for the administration of medicated aerosolized drugs during PEP therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If PEP therapy is combined with medicated aerosol drug delivery, then treatment efficacy is improved, but device complexity increases
Solution Approach 1:
The patent combines a PEP therapy device with a medicated aerosol nebulizer into a single integrated system. The nebulizer is coupled to the PEP device housing, allowing medicated aerosol to be delivered during PEP therapy sessions. This merging of two separate devices (PEP therapy device and aerosol nebulizer) into one unified system enables simultaneous delivery of mechanical therapy and medicated aerosol, thereby improving treatment efficacy for respiratory conditions while managing device complexity through functional integration.
2Adaptability or versatility
If a nebulizer is integrated into the PEP device, then medicated aerosol delivery is enabled, but manufacturing complexity increases
Solution Approach 1:
The PEP device is designed with multi-functionality to serve both as a mechanical therapy device and as a platform for medicated aerosol delivery. The housing includes a nebulizer coupling interface that allows attachment of a medicated aerosol nebulizer, enabling the same device structure to perform multiple functions: providing PEP therapy and delivering medicated aerosol. This universal design approach enables adaptability for treating various respiratory conditions while managing manufacturing complexity by building upon an existing PEP device platform rather than creating an entirely new system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the removal of lung secretions by combining PEP with airway oscillation and intermittent airflow acceleration, improving treatment outcomes for conditions like COPD and cystic fibrosis by effectively delivering medicated aerosols during therapy sessions.
Implementation Method 1
a medicated aerosol nebulizer for the selective administration of medicated oscillatory PEP therapy
Implementation Method 2
an expiratory-air-driven oscillatory rocker assembly that generates oscillatory pressure
Data Source
AI summary
A positive oscillatory expiratory air pressure respiratory therapy device (1000) which is adapted to receive a nebulizer (5) for administering aerosolized medicant for selective administration during oscillatory positive expiratory pressure (PEP) therapy.